Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 Oct 31;13(1):18757.
doi: 10.1038/s41598-023-43266-9.

The effect of metformin therapy on serum thyrotropin and free thyroxine concentrations in patients with type 2 diabetes: a meta-analysis

Affiliations
Meta-Analysis

The effect of metformin therapy on serum thyrotropin and free thyroxine concentrations in patients with type 2 diabetes: a meta-analysis

Alireza Amirabadizadeh et al. Sci Rep. .

Abstract

Type 2 diabetes and thyroid function disorders are two common chronic endocrine disorders with the high prevalence in various populations. Metformin is well established as the first-line drug therapy for managing diabetes mellitus. In this meta-analysis, we aimed to determine the effect of metformin on serum TSH and FT4 concentrations in patients with type 2 diabetes. We searched PubMed, Scopus, web of science, Cochrane library, and google scholar to collect information on the effect of metformin on serum TSH and FT4 levels. Demographic and clinical information and serum TSH and FT4 concentrations before and after metformin treatment were extracted. Studies on patients over 18 years of age were included. A total of 11 studies including 1147 patients were selected for the final analysis. In hypothyroid patients, the TSH level decreased significantly after treatment with metformin (Hedges's g:1.55, 95%CI 0.93-2.16, p-value < 0.001); FT4 level increased slightly after taking metformin, but the increase was not significant (Heddges's g: - 0.30, 95%CI - 0.90,0.31, p-value = 0.34). In euthyroid subjects, the slight decrease found in TSH and FT4 concentrations was not statistically significant. Metformin reduces TSH levels in hypothyroid patients; however, it has no effect on TSH levels in euthyroid patients. Metformin does not affect serum FT4 levels in euthyroid and hypothyroid patients.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Flow diagram demonstrating the study selection for meta-analysis. # Three studies were performed on hypothyroid and euthyroid patients.
Figure 2
Figure 2
Risk assessment bias for the meta-analysis.
Figure 3
Figure 3
Forest plot to compare serum TSH levels before and after metformin therapy in euthyroid patients.
Figure 4
Figure 4
Forest plot to compare serum FT4 levels before and after metformin therapy in euthyroid patients.
Figure 5
Figure 5
Forest plot to compare serum TSH levels before and after metformin therapy in hypothyroid patients under LT4 monotherapy.
Figure 6
Figure 6
Forest plot to compare serum FT4 levels before and after metformin therapy in hypothyroid patients under LT4 monotherapy.

References

    1. Hollowell JG, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National health and nutrition examination survey (NHANES III) J. Clin. Endocrinol. Metab. 2002;87:489–499. doi: 10.1210/jcem.87.2.8182. - DOI - PubMed
    1. Delshad H, Mehran L, Tohidi M, Assadi M, Azizi F. The incidence of thyroid function abnormalities and natural course of subclinical thyroid disorders, Tehran, IR Iran. J. Endocrinol. Invest. 2012;35:516–521. - PubMed
    1. Derakhshan A, et al. Sex specific incidence rates of type 2 diabetes and its risk factors over 9 years of follow-up: Tehran lipid and glucose study. PLoS ONE. 2014;9:e102563. doi: 10.1371/journal.pone.0102563. - DOI - PMC - PubMed
    1. Talwalkar P, Deshmukh V, Bhole M. Prevalence of hypothyroidism in patients with type 2 diabetes mellitus and hypertension in India: a cross-sectional observational study. Diabetes, Metab. Syndr. Obes.: Targets Ther. 2019;12:369. doi: 10.2147/DMSO.S181470. - DOI - PMC - PubMed
    1. Apostolova N, et al. Mechanisms of action of metformin in type 2 diabetes: Effects on mitochondria and leukocyte-endothelium interactions. Redox Biol. 2020;34:101517. doi: 10.1016/j.redox.2020.101517. - DOI - PMC - PubMed

Publication types